Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Recent findings suggest that modifiable lifestyle factors such as education level and physical health measurably impact the risk of young-onset dementia. These insights are crucial for early intervention strategies in clinical practice.
Neurology May 14th 2024
The proposed shift of marijuana to a Schedule III drug highlights its recognized medical applications and potential to treat conditions like anxiety and chronic pain, offering a safer alternative to traditional treatments.
Family Medicine/General Practice May 14th 2024
The New England Journal of Medicine
In a recent clinical trial, thrombectomy combined with medical care was shown to significantly improve functional outcomes in patients with large acute strokes, reducing mortality rates to 36.1% compared to 55.5% in those receiving only medical care.
MD Newsline
Recent systematic reviews suggest a subtle increase in NMOSD and MS risks post-COVID-19 vaccination, primarily affecting genetically susceptible individuals.
Neurology May 7th 2024
Nicotinamide supplementation has been linked to improvements in neurodegenerative symptoms by addressing amyloid-beta and tau pathologies, neuroinflammation, and mitochondrial dysfunction, offering potential therapeutic benefits for conditions like Alzheimer’s disease.
The case highlights the diagnostic challenges and complexities in unraveling rare neurological presentations, necessitating a comprehensive and multidisciplinary approach to patient care.
Neurology April 30th 2024